688617 惠泰医疗
2026/06 - 中期
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额549,285967,760743,390689,058367,455
投资活动产生之现金流量净额95,029(519,182)(617,792)581,901(134,525)
筹资活动产生之现金流量净额(544,387)(279,744)(307,899)(246,358)(294,598)
汇率变动对现金及现金等价物的影响(15,865)(3,791)(13,003)2,840958
现金及现金等价物净增加/(减少)84,062165,043(195,303)1,027,440(60,710)
期初现金及现金等价物余额1,246,1311,081,0881,276,391248,951309,661
期末现金及现金等价物余额1,330,1931,246,1311,081,0881,276,391248,951